AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.3980
-0.0070 (-1.73%)
Apr 21, 2025, 4:00 PM EDT - Market closed

AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $4.19 million. The enterprise value is $17.13 million.

Market Cap 4.19M
Enterprise Value 17.13M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

AEON Biopharma has 10.53 million shares outstanding. The number of shares has decreased by -99.25% in one year.

Current Share Class 10.53M
Shares Outstanding 10.53M
Shares Change (YoY) -99.25%
Shares Change (QoQ) +1.19%
Owned by Insiders (%) 0.33%
Owned by Institutions (%) 12.34%
Float 10.36M

Valuation Ratios

The trailing PE ratio is 0.01.

PE Ratio 0.01
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio -0.15
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.41
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.11

Current Ratio 0.11
Quick Ratio 0.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -348.25%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 252.78%
Revenue Per Employee n/a
Profits Per Employee $8.40M
Employee Count 5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.88% in the last 52 weeks. The beta is 0.35, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y) 0.35
52-Week Price Change -99.88%
50-Day Moving Average 2.45
200-Day Moving Average 48.22
Relative Strength Index (RSI) 23.88
Average Volume (20 Days) 470,600

Short Selling Information

The latest short interest is 210,177, so 2.00% of the outstanding shares have been sold short.

Short Interest 210,177
Short Previous Month 393,233
Short % of Shares Out 2.00%
Short % of Float 2.03%
Short Ratio (days to cover) 0.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -27.82M
Pretax Income n/a
Net Income 42.01M
EBITDA -27.73M
EBIT -27.82M
Earnings Per Share (EPS) $72.93
Full Income Statement

Balance Sheet

The company has $13,000 in cash and $12.96 million in debt, giving a net cash position of -$12.94 million or -$1.23 per share.

Cash & Cash Equivalents 13,000
Total Debt 12.96M
Net Cash -12.94M
Net Cash Per Share -$1.23
Equity (Book Value) -28.57M
Book Value Per Share -51.43
Working Capital -12.56M
Full Balance Sheet

Cash Flow

Operating Cash Flow -20.29M
Capital Expenditures n/a
Free Cash Flow -20.29M
FCF Per Share -$1.93
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 99.25%
Shareholder Yield 99.25%
Earnings Yield 1,002.01%
FCF Yield -484.06%

Analyst Forecast

The average price target for AEON Biopharma is $360.00, which is 90,352.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target $360.00
Price Target Difference 90,352.26%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.01388889:1.

Last Split Date Feb 26, 2025
Split Type Reverse
Split Ratio 0.01388889:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1